Anthony Mullin | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Mr. Anthony Mullin | Pharmaceutical Science | Best Researcher Award

PhD Research Molecular Biology, University of Hertfordshire, United Kingdom

Anthony James Mullin is a dedicated researcher with a profound passion for advancing knowledge in tissue culture management and forensic analytical chemistry. His strong academic background and extensive experience in both research and commercial settings make him a vital contributor to the fields of cancer research and psychoactive substance analysis.

Profile

Orcid

Strengths for the Award

Anthony Mullin demonstrates a solid foundation of research expertise, particularly in areas such as psychopharmacology, drug misuse, and analytical chemistry. His work, especially in forensic analysis and the study of New Psychoactive Substances (NPS), reflects innovative approaches, such as applying AI for historical drug misuse trend analysis. His collaboration with renowned researchers like Professor Schifano and Dr. Guirguis further highlights his contributions. Mullin’s research has been recognized at international conferences, underscoring its impact and relevance. His Oxford Press Award for Outstanding Achievements in Bioscience adds to his credibility. Mullin’s well-rounded skill set, including tissue culture management and advanced drug stability analysis, combined with his technical proficiency (e.g., UHPLC, GCMS) and multidisciplinary publications, strengthens his candidacy for the award.

Areas for Improvement

While Mullin’s research portfolio is impressive, his Research Influence (RI) score of 7.0 could benefit from more citations to increase visibility and impact within the academic community. His work, although influential in niche areas, might gain broader recognition by focusing on publishing in higher-impact journals and increasing collaboration beyond his current research groups. Additionally, more outreach and involvement in global networks could amplify his contributions. Although he has presented at international conferences, consistent engagement with the wider research community through more frequent publications and presentations could enhance his profile.

Education 🎓

Anthony graduated with a 1st Class BSc (Hons) in Chemical Biology from the University of Hertfordshire in 2012. His remarkable academic performance earned him the prestigious Oxford Press Award for Outstanding Achievements in Bioscience, underscoring his commitment to excellence in the field of biosciences.

Experience 💼

Anthony has served as a Freelance Research Assistant and Author at the University of Hertfordshire and Swansea University, where he worked within the Psychopharmacology, Drug Misuse, and NPS research group. His previous roles include Research Assistant and Laboratory Technician at the University of Hertfordshire, as well as positions in scientific recruitment and quality control analysis. His diverse experience has equipped him with a unique skill set that bridges the gap between scientific research and practical application.

Research Interests 🔬

Anthony’s research interests are centered around tissue culture management, bio-assay development, and the forensic analysis of new psychoactive substances (NPS). He is particularly interested in utilizing artificial intelligence to enhance analytical methodologies and improve drug stability testing processes.

Awards 🏆

Anthony has received several accolades, including the Oxford Press Award for Outstanding Achievements in Bioscience for his exceptional academic performance. His contributions to research have also led to presentations at prestigious conferences, further establishing him as a respected figure in his field.

Publications Top Notes 📝

  1. Mullin, A., Scott, M., Vaccaro, G., Floresta, G., Arillotta, D., Catalani, V., Corkery, J.M., Stair, J.L., Schifano, F., Guirguis, A. (2024). Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques. Pharmacy 12, 13.
    • Citations: 0
  2. Mullin, A., Scott, M., Vaccaro, G., Gittins, R., Ferla, S., Schifano, F., Guirguis, A. (2023). Handheld Raman Spectroscopy in the First UK Home Office Licensed Pharmacist-Led Community Drug Checking Service. Int. J. Environ. Res. Public Health 20, 4793.
    • Citations: 3
  3. Williams D T, Straw N, Townsend M, Wilkinson A S, and Mullin, A. (2013). Monitoring oak processionary moth Thaumetopoea processionea L. using pheromone traps: the influence of pheromone lure source, trap design and height above the ground on capture rates. Agricultural and Forest Entomology 15, pp.126–134.
    • Citations: 20

Conclusion

Anthony Mullin is a promising researcher with significant achievements in psychopharmacology, drug misuse, and analytical chemistry. His technical skills, innovative approaches, and notable academic accomplishments make him a strong candidate for the “Best Researcher Award.” With targeted efforts to increase the visibility and impact of his work, particularly through citations and global collaboration, Mullin could further solidify his standing in the research community

Samer Younes | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Dr. Samer Younes | Pharmacology | Best Researcher Award

Department of Pharmacy, Tartous University, Syria

🌟 Samer Younes is a dedicated and forward-thinking pharmacy graduate from Tartous University, Syria. With a strong academic background and diverse experience in both practical pharmacy and research, Samer is committed to continuous learning and professional development. His work ethic is demonstrated through his active participation in community volunteering, internships, and a keen interest in expanding his expertise in the field of pharmacy and nutrition.

Profile

Google Scholar

Research for “Best Researcher Award”

Strengths for the Award

1. Strong Academic Foundation and Practical Experience:
Samer Younes has demonstrated a solid academic foundation with a Bachelor’s degree in Pharmacy from Tartous University, complemented by practical experience in various pharmacy roles and internships. His work as a pharmacist involved crucial tasks such as prescription processing and handling patient queries, showcasing his applied knowledge in the field.

2. Commitment to Continuous Learning and Professional Development:
Samer’s commitment to professional growth is evident from his various certifications, including Quality Advisor and specialized training in Nutrition and Laboratory Work. These certifications not only add to his qualifications but also highlight his proactive approach to expanding his skill set and knowledge.

3. Volunteer Experience and Community Engagement:
His volunteer work with UNICEF and involvement in the Campaign against Covid-19 underline his dedication to societal well-being and public health. His role in these initiatives, including vaccinations and monitoring children’s rights, demonstrates his ability to apply his expertise in real-world scenarios and contribute to community health.

4. Language and Digital Skills:
Samer possesses proficiency in multiple languages, which enhances his ability to communicate and collaborate in diverse settings. His digital skills, including expertise in Microsoft Office and analytical tools, are essential for modern research and data analysis.

5. Strong Recommendations:
Samer has received commendations from reputable professors, such as Wissam Zam and Zeina Hamama, who can vouch for his academic prowess and research capabilities. Their recommendations add credibility to his achievements and potential as a researcher.

Areas for Improvement

1. Limited Research Publications:
While Samer has a commendable academic background and practical experience, his publication record appears limited. Expanding his research output and publishing in high-impact journals could enhance his visibility and influence in the field of pharmacy and research.

2. Focused Research Experience:
Although Samer has engaged in diverse roles and projects, a more focused research experience in specific areas of pharmacy or a related field could strengthen his application. Specializing in a niche area and contributing significant research could further solidify his candidacy for the award.

3. Networking and Collaboration:
Building a stronger professional network and engaging in collaborative research projects could provide additional opportunities for growth and recognition. Participating in conferences and research forums would also help him gain further exposure and feedback from the scientific community.

4. Enhanced Research Visibility:
Increasing his presence in research communities, such as ResearchGate and Google Scholar, by regularly updating his profiles and engaging with other researchers could improve his visibility and impact in the research domain.

Education

🎓 Bachelor Degree in Pharmacy
Department of Pharmacy, Tartous University
(01/09/2018 – 31/01/2024)
Samer graduated with a final grade of 72.2/100, having gained a solid foundation in pharmaceutical sciences and practical experience through his coursework and projects.

Experience

💊 Pharmacist
Ghadeer Pharmacy
(01/12/2020 – 19/08/2022)
Samer managed prescription processing, handled patient queries, ensured compliance with pharmacy regulations, and updated inventory information, showcasing his practical expertise in the pharmaceutical field.

🔬 Internship: Campaign Against Covid-19
(12/09/2020 – 12/05/2021)
In this role, Samer contributed to examinations and vaccinations, playing a crucial part in the fight against the pandemic.

🌍 Volunteering: UNICEF
(18/11/2013 – 20/11/2013)
Samer’s work with UNICEF included training and voluntary activities, reflecting his commitment to global health and community support.

Research Interests

Samer’s research interests lie in the intersection of nutrition and pharmacology, particularly focusing on the impact of micronutrients on health conditions and treatment outcomes. His work aims to advance understanding in these areas and contribute to more effective therapeutic strategies.

Awards and Certifications

  • Quality Advisor – Insight (Training Development & Consulting) (24/11/2022 – 28/11/2022)
  • Laboratory Work Level 1+2 – Insight (24/11/2022 – 28/11/2022)
  • Nutrition and Diets – Insight (02/02/2022 – 20/02/2022)
  • Nutrition Basics – Insight (12/12/2021 – 20/12/2021)

Publications Top Notes

  1. The Role of Nutrition on the Treatment of Covid-19
    Human Nutrition & Metabolism, 200255 (2024)
    Cited by: 4
  2. The Role of Micronutrients on the Treatment of Diabetes
    Human Nutrition & Metabolism, 200238 (2024)
    Cited by: 4
  3. The Impact of Micronutrients on the Sense of Taste
    Human Nutrition & Metabolism, 200231 (2023)
    Cited by: 2
  4. The Relationship Between Gender and Pharmacology
    Current Research in Pharmacology and Drug Discovery, 100192 (2024)
    Cited by: 1

Conclusion

Samer Younes exhibits many strengths that align well with the criteria for the “Best Researcher Award.” His academic qualifications, practical experience, and dedication to continuous learning and community service are commendable. To strengthen his candidacy, focusing on increasing his research publications, specializing in a specific area, and enhancing his professional network and visibility will be crucial. With his solid foundation and commitment to growth, Samer has the potential to make significant contributions to the field and be a strong contender for the award.

 

Yan Ni | Pharmaceutical Research | Best Researcher Award

Posted on by ScienceFather

Dr. Yan Ni | Pharmaceutical Research | Best Researcher Award

Executive Director, Passage bio, United States

Profile

Google Scholar

Researcher Evaluation for “Best Researcher Award”

Strengths for the Award:

Extensive Expertise in Drug Development: Yan G. Ni, PhD, has over 15 years of experience in drug development, particularly in small molecules, biologics, and gene therapies. His work spans several critical therapeutic areas, including neurological and cardiovascular diseases, immune-oncology, hematology, and rare diseases. His contributions to IND/CTA submissions and regulatory interactions further highlight his deep involvement in the field.

Leadership in Translational Biomarker and Precision Medicine: Dr. Ni has demonstrated significant expertise in integrating preclinical and clinical biomarker strategies, contributing to the successful design and execution of biomarker-based clinical endpoints. His role in implementing PK and immunogenicity strategies across different phases of studies showcases his ability to bridge the gap between research and clinical application, a crucial factor in modern drug development.

Proven Management Skills: Dr. Ni’s management experience is evident in his ability to build and lead high-performing cross-functional teams. His leadership roles in international professional organizations like the AAPS and SAPA, as well as his track record of mentoring and inspiring others, underline his effectiveness as a leader in both scientific and organizational contexts.

High Scientific Productivity: With over 35 peer-reviewed publications, several book chapters, and six U.S. patents, Dr. Ni’s scientific output is substantial. His contributions to industry white papers and his role as an organizer and invited speaker at national and international conferences further affirm his thought leadership in the field.

Recognition and Awards: Dr. Ni has received numerous prestigious awards, such as the Passage Bio High Impact Award, Regeneron High Impact Award, AAPS Excellence in Ligand Binding Assays Award, and Merck Award of Excellence. These accolades reflect his high-impact contributions to the field and recognition by peers and industry leaders.

Areas for Improvement:

Broader Impact Beyond Specialized Fields: While Dr. Ni’s expertise is well-recognized within specialized areas such as biomarkers, precision medicine, and drug development, expanding his influence into broader, interdisciplinary research domains could enhance his candidacy for a “Best Researcher Award.” For example, engaging in research that impacts public health or other critical global issues might increase his visibility and impact.

Further Innovation in Emerging Therapeutic Areas: While Dr. Ni has made significant contributions to established therapeutic areas, greater involvement in cutting-edge fields such as artificial intelligence in drug discovery or personalized medicine could position him as a pioneer in these rapidly evolving areas.

Enhanced Collaboration with Global Initiatives: Although Dr. Ni has demonstrated leadership in professional organizations and consortia, expanding his collaborative efforts to include global health initiatives or large-scale, multi-national research projects could further amplify his contributions and align with broader global research priorities.

Professional Experience

Passage Bio, Philadelphia, PA
Executive Director, Biomarkers and Precision Medicine
2021-Present
Senior Director, Head of Biomarkers and Precision Medicine
2020-2021

Built and led a high-performing team responsible for driving clinical biomarker, PK/biodistribution, immunogenicity studies, and supporting clinical operations.

Developed and implemented biomarker, PK, and immunogenicity strategies to inform decision-making for neurodegenerative disease portfolios.

Led biomarker and precision medicine support for IND/CTA submissions and global regulatory interactions.

Oversaw partnerships with external CROs and laboratories, and collaborated with Clinical Study Teams on biomarker inclusion in clinical portfolios.

Regeneron, Tarrytown, NY
Associate Director, Precision Medicine, Early Clinical Development & Experimental Sciences
2016-2020

Designed and implemented biomarker strategies to support dose selection and efficacy readings for complement-mediated rare diseases.

Provided strategic leadership for discovery and early cardiovascular programs, influencing biomarker-driven decisions on target validation, disease indication selection, and patient stratification.

Led multiple biomarker-focused natural history studies with academic and clinical centers.

Bristol Myers Squibb, Princeton, NJ
Senior Research Investigator II, R&D/PD/ABD/BAS-Biologics
2012-2016

Supported biomarker bioanalytical strategy implementation for immuno-oncology, immunology, and cardiovascular diseases.

Supervised biomarker method development and validation by internal staff and CROs.

Provided strategic and technical input on biomarker bioanalytical plans, resources, and timelines for FIH and PoC studies.

Merck & Co., Inc., Rahway, NJ
Senior Research Scientist, Cardiovascular Franchise Atherosclerosis Group
2007-2011

Led the development of a 2nd generation fully human monoclonal antibody for PCSK9.

Established ELISA-based pharmacodynamics and target engagement biomarker assays.

University of Texas Southwestern Medical Center, Dallas, TX
Research Assistant Professor, Internal Medicine Department, Cardiology
2001-2007
Research Scientist, Department of Pharmacology & Alliance for Cellular Signaling
2001-2007

Conducted research on cardiac hypertrophy, heart failure, and aging, focusing on Akt and FOXO transcriptional factors.

Education and Training

Persuasive Leadership Development: Wharton Business School, University of Pennsylvania

Postdoctoral Training: Yale University, under Professors Gary Rudnick and Eric Nestler

Ph.D. in Neuroscience: University of California, Irvine, under Professor Ricardo Miledi

M.S. in Pharmacology: Institute of Basic Medical Sciences, Beijing, China

B.S. in Biochemistry: Anhui University, Hefei, China

Professional Honors

Passage Bio High Impact Award (2021)

Regeneron High Impact Award and Multiple STAR Awards (2016-2020)

AAPS Excellence in Ligand Binding Assays Award (2015)

BMS R&D ROC Award and Multiple STAR Awards (2014)

Merck Award of Excellence (2007, 2008, 2009)

Professional Affiliations

American Association of Pharmaceutical Scientists (AAPS):

Founding Member and Chair of the Biomarkers and Translational Medicine Community

Founding Member and Chair of the Gene and Cell Therapeutic Products Community

Sino-American Pharmaceutical Professionals Association (SAPA):

Director for Public Outreach and Executive Committee Member

Publications

Yang, J., Mapelli, C., Wang, Z., et al. (2022). An Optimized Agonist Peptide of Protease-activated Receptor 4 and its Use in a Platelet Aggregation Assay to Monitor the Pharmacodynamic Effects of PAR4 Antagonists. Platelets. DOI: 10.1080/09537104.2022.2053091

Hays, A., Amaravadi, L., Fernandez-Metzler, C., et al. (2022). Is Incurred Sample Reanalysis (ISR) applicable in Biomarker Assays? AAPS J, 24:65. DOI: 10.1208/s12248-022-00708-y

Ni, Y.G., King, L., Fernández-Metzler, C. (2022). Recent Progress in Biomarker Bioanalysis and Target Engagement in Bioanalytical Aspects in Biological Therapeutics. ISBN: 9781119523215. Edited by Xu, X. & Xu, W.

Conclusion:

Dr. Yan G. Ni, PhD, is an outstanding candidate for the “Best Researcher Award” based on his extensive contributions to drug development, biomarker research, and precision medicine. His leadership, scientific productivity, and recognition by peers make him a strong contender for the award. However, expanding his research impact into broader and more emerging fields could further strengthen his profile for this prestigious recognition.